# Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke

> **NCT07301372** · PHASE4 · COMPLETED · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 132 (actual)

## Conditions studied

- Acute Stroke

## Interventions

- **DRUG:** Ivolumab 420mg (three vials)

## Key facts

- **NCT ID:** NCT07301372
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-30
- **Primary completion:** 2026-04-29
- **Final completion:** 2026-04-29
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07301372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07301372, "Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07301372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*